All Stories

  1. Seroprevalence of Hepatitis A among Children and Young Adults Residing in Tehran, Iran: Implication for HAV Vaccination
  2. Seroprevalence, molecular epidemiology and quantitation of parvovirus B19 DNA levels in Iranian blood donors
  3. Seroprevalence, Molecular Epidemiology and Quantitation of Parvovirus B19 DNA levels in Iranian Blood Donors
  4. Preventive Human Papillomavirus (HPV) Vaccines: Immunogenicity, Efficacy and Safety
  5. Gender and age-specific seroprevalence of human papillomavirus 16 and 18 in general population in Tehran, Iran
  6. Low prevalence of hepatitis B vaccine escape mutants among individuals born after the initiation of a nationwide vaccination program in Iran
  7. Occult hepatitis B virus infection and S gene escape mutants in HIV-infected patients after hepatitis B virus vaccination
  8. No evidence of persistent parvovirus B19 viremia among Iranian patients with HIV after a 1-year follow-up
  9. Interlukine-17 and TGF-β levels in patients with acute brucellosisbefore and after treatment
  10. Frequency and Genotype of Human Parvovirus B19 among Iranian Hemodialysis and Peritoneal Dialysis Patients
  11. Frequency and subtype of BK virus infection in Iranian patients infected with HIV
  12. Significance of hepatitis E virus infection in HIV-infected patients: a challenging issue
  13. Frequency and genotype of human parvovirus B19 among Iranian patients infected with HIV
  14. Prevalence of BK viremia in Iranian hemodialysis and peritoneal dialysis patients
  15. Isolated Anti-HBc and Occult HBV Infection in Dialysis Patients
  16. Immune Response to Standard Hepatitis B Vaccination in HIV-Infected Patients
  17. Comparison of two durations of triple-drug therapy in patients with uncomplicated brucellosis: A randomized controlled trial
  18. HCV, HBV, and HIV seroprevalence, coinfections, and related behaviors among male injection drug users in Arak, Iran
  19. Serological response to one intradermal or intramuscular hepatitis B virus vaccine booster dose in human immunodeficiency virus-infected nonresponders to standard vaccination
  20. Importance of Isolated Anti-HBc in Detection of Occult Hepatitis B Virus Infection in Hemodialysis Patients
  21. Hepatitis E virus infection in patients infected with human immunodeficiency virus in an endemic area in Iran
  22. No Correlation Between Interleukin-10 Gene Promoter Polymorphisms and Hepatitis B Virus Infection Outcome
  23. Frequency and Genotype of Hepatitis D Virus Infection in Patients Infected with HIV and Those Undergoing Hemodialysis
  24. Serum Profile of T Helper 1 and T Helper 2 Cytokines in Hepatitis C Virus Infected Patients
  25. Viral Hepatitis and HIV Infection Among Injection Drug Users in a Central Iranian City
  26. Occult hepatitis B infection in different high risk patients
  27. Viral Hepatitis and HIV Infection in Hemodialysis Patients
  28. Occult Hepatitis B Virus Infection in Hemodialysis Patients: A Concept for Consideration
  29. The Influence of Human Leukocyte Antigen and IL-10 Gene Polymorphisms on Hepatitis B Virus Outcome
  30. Persistence of antibody to hepatitis B surface antigen among vaccinated children in a low hepatitis B virus endemic area
  31. Reply to Letter to the Editor: Occult Hepatitis B Virus Infection in Hemodialysis Patients With Isolated Hepatitis B Core Antibody: A Multicenter Study
  32. Serological pattern of anti-HBc alone infers occult hepatitis B virus infection in high-risk individuals in Iran
  33. The role of human papillomavirus infection in prostate carcinoma
  34. Assessing subtype and drug-resistance-associated mutations among antiretroviral-treated HIV-infected patients
  35. Seroepidemiology of hepatitis A virus in children of different age groups in Tehran, Iran: Implications for health policy
  36. Lack of occult hepatitis B virus infection among blood donors with isolated hepatitis B core antibody living in an HBV low prevalence region of Iran
  37. Surface gene mutations of hepatitis B virus among high-risk patients with occult hepatitis B virus infection
  38. Occult Hepatitis B Virus Infection in Hemodialysis Patients With Isolated Hepatitis B Core Antibody: A Multicenter Study
  39. Hepatitis B virus genotype in Iranian patients with hepatocellular carcinoma
  40. Comparison of QuantiFERON TB-G-test to TST for detecting latent tuberculosis infection in a high-incidence area containing BCG-vaccinated population
  41. Frequency and genotype of GB virus C among Iranian patients infected with HIV
  42. Association of human leukocyte antigen polymorphism with outcomes of hepatitis B virus infection
  43. Frequency and associated factors of proteinuria in Iranian HIV-positive patients
  44. Rate of YMDD motif mutants in lamivudine-untreated Iranian patients with chronic hepatitis B virus infection
  45. Persistence of Hepatitis B Vaccine Immunity in Hemodialysis Patients
  46. Risk factors for human brucellosis in Iran: a case–control study
  47. Occult Hepatitis B Virus Infection in HIV-Infected Patients with Isolated Hepatitis B Core Antibody
  48. Hepatitis G Virus Exposure in Dialysis Staff
  49. Hepatitis G virus exposure in dialysis patients
  50. Frequency of human papillomavirus infection in oesophageal squamous cell carcinoma in Iranian patients
  51. P53, cyclin D1 and Rb genes expression changes in esophageal squamous cell carcinoma in iran